Answers are grounded in this paper and cite their sources.
Accurate differentiation between benign parotid gland tumors (BPGT) and malignant parotid gland tumors (MPGT) is of paramount importance for clinical decision-making and treatment planning. Early and precise diagnosis can significantly influence the choice of therapeutic strategies, patient prognosis, and overall survival rates. Given the clinical significance of distinguishing between BPGT and MPGT, the present study aims to develop a nomogram model that integrates clinical information, ultrasound parameters, and radiomics features extracted from gray-scale ultrasound images to differentiate between BPGT and MPGT. Furthermore, the model’s performance will be evaluated using Shapley Additive Explanations (SHAP) analysis. This retrospective and prospective study examined grayscale ultrasound images from 425 patients diagnosed with parotid gland tumors. 242 patients from Center1 and Center2 constituted the training cohort (including 197 BPGT and 45 MPGT), while 104 patients from Center3 served as the external validation cohort (including 80 BPGT and 24 MPGT). Additionally, 79 patients were prospectively collected from three centers (including 63 BPGT and 16 MPGT) for the prospective validation cohort. Clinic model was developed using clinical data and ultrasound visual information. Radiomics features were extracted from the grayscale ultrasound images to construct radiomics models and corresponding Rad-score. Integrating the Rad score and clinical factors, through multiple logistic regression analysis, to draw a nomogram. These models’ performance was evaluated utilizing receiver operating characteristic (ROC) curve analysis, calibration curves, decision curve analysis (DCA), and the Hosmer-Lemeshow (HL) test. Additionally, SHAP analysis was employed to enhances interpretability in the Rad mode by quantifying and visualizing the impact of each feature on predictions, providing clear insights into model behavior. Four ultrasound visual features were selected using logistic regression (LR) to develop the clinical model, while nineteen features were ultimately chosen from the grayscale ultrasound images through feature screening to construct the radiomics (Rad) model. In the external and prospective validation cohort, compared with Clinic (ACC = 0.769 and 0.785) and Rad (ACC = 0.827 and 0.810), the nomogram showed the best discriminative ability (ACC = 0.817 and 0.848). The nomogram model integrating clinical features and radiomics features constructed in this study has demonstrated higher accuracy and robustness in differentiating BPGT and MPGT. SHAP analysis has enhanced the transparency and interpretability of the model. The model not only support clinical diagnosis and help reduce unnecessary biopsies and surgeries, but also lay the foundation for future multimodal precise diagnosis of parotid gland tumors.
No takes yet. Share an insight, caveat, or question.
Mao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: